Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention

被引：1
|
作者：
Manuck, Tracy A. [1 ,2 ,3 ,4 ]
Watkins, Scott [2 ]
Esplin, M. Sean [2 ,3 ,4 ]
Parry, Samuel [4 ,5 ]
Zhang, Heping [4 ,6 ]
Huang, Hao [4 ,6 ]
Biggio, Joseph R. [4 ,7 ]
Bukowski, Radek [4 ,6 ]
Saade, George [4 ,8 ]
Andrews, William [4 ,7 ]
Baldwin, Don [4 ,5 ]
Sadovsky, Yoel [4 ,9 ]
Reddy, Uma [4 ,10 ]
Ilekis, John [4 ,10 ]
Varner, Michael W. [2 ,3 ,4 ]
Yandell, Mark [2 ]
Jorde, Lynn B. [2 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Intermt Healthcare, Salt Lake City, UT USA
[4] Genom & Prote Network Preterm Birth Res GPN, Bethesda, MD USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Yale Univ, New Haven, CT USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Texas Med Branch, Galveston, TX 77555 USA
[9] Univ Pittsburgh, Pittsburgh, PA USA
[10] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2016年 / 214卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2015.10.034
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
12
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [31] Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
    Brancazio, LR
    Murtha, AP
    Heine, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1087 - 1087
  • [32] Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth
    Fried, Inbar
    Beam, Andrew L.
    Kohane, Isaac S.
    Palmer, Nathan P.
    JAMA INTERNAL MEDICINE, 2017, 177 (11) : 1689 - 1690
  • [33] Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
    Meis, PJ
    Klebanoff, M
    Thom, E
    Dombrowski, MP
    Sibai, B
    Moawad, AH
    Spong, CY
    Hauth, JC
    Miodovnik, M
    Varner, MW
    Leveno, KJ
    Caritis, SN
    Iams, JD
    Wapner, RJ
    Conway, D
    O'Sullivan, MJ
    Carpenter, M
    Mercer, B
    Ramin, SM
    Thorp, JM
    Peaceman, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24): : 2379 - 2385
  • [34] Effect of 17-alpha hydroxyprogesterone caproate on labor at preterm gestations
    Judy, Amy E.
    El-Sayed, Yasser Y.
    Blumenfeld, Yair J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S294 - S294
  • [35] Defining the clinical response to 17-alpha hydroxyprogesterone caproate
    Caritis, Steve N.
    Hauspurg, Alisse
    Venkataramanan, Raman
    Lemon, Lara
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (06) : 623 - 625
  • [36] 17 α-Hydroxyprogesterone Caproate (Makena™)In the Prevention of Preterm Birth
    Emma D. Deeks
    Pediatric Drugs, 2011, 13 : 337 - 345
  • [37] 17 α-Hydroxyprogesterone Caproate (Makena™) In the Prevention of Preterm Birth
    Deeks, Emma D.
    PEDIATRIC DRUGS, 2011, 13 (05) : 337 - 345
  • [38] Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system
    Manuck, Tracy A.
    Stoddard, Gregory J.
    Fry, Rebecca C.
    Esplin, M. Sean
    Varner, Michael W.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (05) : 622.e1 - 622.e8
  • [39] PROPHYLACTIC ADMINISTRATION OF 17 ALPHA-HYDROXYPROGESTERONE CAPROATE (17P) IN CLINICAL PRACTICE: THE IMPACT ON RATES OF PRETERM BIRTH
    Rebarber, Andrei
    Fox, Nathan S.
    Klauser, Chad K.
    Gandhi, Manisha
    Rhea, Debbie
    Istwan, Niki
    Stanziano, Gary
    Saltzman, Daniel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S96 - S96
  • [40] The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth
    Nelson, David B.
    Herrera, Christina L.
    McIntire, Donald D.
    Cunningham, F. Gary
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : 1 - 9
12345